| 000 | 01401 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512205808.0 | ||
| 264 | 0 | _c19831123 | |
| 008 | 198311s 0 0 eng d | ||
| 022 | _a0025-7125 | ||
| 024 | 7 |
_a10.1016/s0025-7125(16)31170-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKit, M | |
| 245 | 0 | 0 |
_aViral vaccines. _h[electronic resource] |
| 260 |
_bThe Medical clinics of North America _cSep 1983 |
||
| 300 |
_a1129-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aCapsid _xanalysis |
| 650 | 0 | 4 | _aDNA, Recombinant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, Viral |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xanalysis |
| 650 | 0 | 4 | _aHepatitis B Vaccines |
| 650 | 0 | 4 |
_aHepatitis B virus _xanalysis |
| 650 | 0 | 4 |
_aHerpes Genitalis _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza A virus _xpathogenicity |
| 650 | 0 | 4 | _aInfluenza Vaccines |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPoliovirus _xpathogenicity |
| 650 | 0 | 4 |
_aSimplexvirus _xgenetics |
| 650 | 0 | 4 | _aVaccines, Attenuated |
| 650 | 0 | 4 |
_aViral Proteins _ximmunology |
| 650 | 0 | 4 | _aViral Vaccines |
| 650 | 0 | 4 | _aVirulence |
| 700 | 1 | _aKit, S | |
| 773 | 0 |
_tThe Medical clinics of North America _gvol. 67 _gno. 5 _gp. 1129-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0025-7125(16)31170-1 _zAvailable from publisher's website |
| 999 |
_c6312138 _d6312138 |
||